Region:Middle East
Author(s):Rebecca
Product Code:KRAC9681
Pages:98
Published On:November 2025

By Type:The market is segmented into Diagnostic Imaging, Biomarker Testing, Genetic Testing, Neurological Assessments, and Laboratory-based Assays. Diagnostic Imaging remains the leading sub-segment, accounting for the largest market share due to its essential role in accurately diagnosing neurodegenerative conditions in animals. The adoption of advanced imaging modalities such as MRI and CT scans is increasing in Saudi veterinary practices, enabling earlier and more precise detection of neurological disorders. The growing demand for minimally invasive, high-resolution diagnostic solutions among pet owners is accelerating the uptake of these technologies .

By End-User:The end-user segmentation comprises Veterinary Clinics, Animal Hospitals, Veterinary Diagnostic Laboratories, Research Institutions, Pet Owners, and Others. Veterinary Clinics are the dominant end-user segment, reflecting their accessibility and the increasing number of pet owners seeking regular and preventive health check-ups for their animals. The shift toward preventive healthcare and early intervention in pets has led to a rise in diagnostic testing volumes in clinics, reinforcing their leading position in the market .

The KSA Veterinary Neurodegenerative Disease Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as IDEXX Laboratories, Inc., Zoetis Inc., Neogen Corporation, Virbac S.A., Heska Corporation, Vetoquinol S.A., Abaxis (a Zoetis company), Elanco Animal Health Incorporated, Boehringer Ingelheim Animal Health, Antech Diagnostics, Inc., PetDx, ACUVET Biotech, Avacta Animal Health Limited, National Veterinary Diagnostic Laboratory (Saudi Arabia), Life Diagnostics, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
The future of the KSA veterinary neurodegenerative disease diagnostics market appears promising, driven by technological advancements and increasing pet ownership. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency, while the growth of telemedicine will facilitate remote consultations. Additionally, as pet owners prioritize preventive healthcare, the demand for innovative diagnostic solutions will likely rise, creating a dynamic environment for market expansion and improved animal health outcomes.
| Segment | Sub-Segments |
|---|---|
| By Type | Diagnostic Imaging (MRI, CT, X-ray) Biomarker Testing (Protein, Enzyme, Genetic Markers) Genetic Testing (DNA, RNA-based Assays) Neurological Assessments (Behavioral, Cognitive Tests) Laboratory-based Assays |
| By End-User | Veterinary Clinics Animal Hospitals Veterinary Diagnostic Laboratories Research Institutions Pet Owners Others |
| By Animal Type | Dogs Cats Horses Exotic Pets Livestock Others |
| By Diagnostic Method | Blood Tests Imaging Techniques (MRI, CT, X-ray) Neurological Evaluations Biopsy Procedures Molecular Diagnostics Others |
| By Distribution Channel | Direct Sales Online Sales Distributors Veterinary Conferences and Trade Shows Others |
| By Region | Central Region Eastern Region Western Region Southern Region |
| By Policy Support | Government Subsidies Tax Incentives Research Grants Regulatory Support Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Veterinary Clinics | 60 | Veterinarians, Clinic Managers |
| Diagnostic Laboratories | 40 | Lab Directors, Technical Managers |
| Pet Owners | 100 | Pet Owners, Animal Welfare Advocates |
| Academic Institutions | 50 | Veterinary Researchers, Professors |
| Government Agencies | 40 | Policy Makers, Veterinary Health Officials |
The KSA Veterinary Neurodegenerative Disease Diagnostics Market is valued at approximately USD 6 million, reflecting its specialized role within the broader Saudi veterinary diagnostics market, which exceeds USD 125 million.